Dexcom, Inc.
UnclaimedIn-Vitro Diagnostic Substance ManufacturingSan Diego, CA
Founded
1999
Primary NAICS
325413
CAGE code
1YZV8
Federal awards
—
Overview
Dexcom Continuous Glucose Monitoring is simplifying diabetes management with a small device, accurate real-time glucose readings, and proven results.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Capabilities
Medical and Surgical Instruments, Equipment, and Supplies
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $0 | 12 |
| 2025 | Department of Veterans Affairs | $0 | 8 |
| 2024 | Department of Veterans Affairs | $0 | 4 |
| 2023 | Department of Veterans Affairs | $0 | 7 |
| 2022 | Department of Veterans Affairs | $0 | 4 |
| 2022 | Department of Health and Human Services | -$1,500 | 1 |